WASHINGTON, D.C.—Womble Bond Dickinson attorney Dan Orr will teach a section of the Food & Drug Law Institute course Introduction to Biologics and Biosimilars Law and Regulation. The course will take place in Washington, D.C. on April 2-3. Orr will teach a section concerning how FDA reviews biological products and makes its approval decisions. 

Dan Orr is a Partner in the Washington, D.C. office of Womble Bond Dickinson. He advises clients concerning regulatory and patent issues in the pharmaceutical, biotech, and medical device sectors. Before joining WBD in January 2018, Orr was a Regulatory Counsel in FDA’s Center for Drug Evaluation & Research where he solved regulatory problems in a portfolio of drugs and biologics with combined annual sales of more than $37 billion.